by Administrators Qynapse | Sep 19, 2021 | News
BOSTON, MA, September 20, 2021, PRNewswire – Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, unveils a full rebrand including new logo and a complete website redesign,...
by Administrators Qynapse | Sep 9, 2021
Peace of Mind. The future of neuroimaging is here. Why Qynapse? Peace of Mind. Why Qynapse? The future of neuroimaging analysis is here and Qynapse is leading the way. For clinicians on the front lines, for patients and their families, for payers, and for pharma – we...
by Administrators Qynapse | Sep 8, 2021
QyScore® produces a wide range of automated neuroimaging biomarkers to assist physicians making clinical care decisions and monitoring patients over time. QyScore® is FDA-Cleared, CE-Marked and soon expanding into new global markets. QyScore® also has demonstrated...
by Administrators Qynapse | Sep 8, 2021
by Administrators Qynapse | Sep 8, 2021
Peace of Mind. The future of neuroimaging is here. Why Qynapse? Peace of Mind. Why Qynapse? The future of neuroimaging analysis is here and Qynapse is leading the way. For clinicians on the front lines, for patients and their families, for payers, and for pharma – we...